Responding to inquiries from the House Budget Committee, the Congressional Budget Office (CBO) has signaled its openness to examining new…
Browsing: Drug Pricing
On November 20, 2023, the House Budget Committee addressed a letter to the Congressional Budget Office (CBO), expressing concerns and…
Recently, Aimed Alliance submitted a comment to the Centers for Medicaid and Medicare Services (CMS) on the Patient Listening Sessions…
A recent report by the Alliance for Patient Access (AfPA) titled “At What Price? Medication Value, Patient Care & the…
A recent report by the Government Accountability Office found that despite the substantial rebates private plans received for Medicare Part…
On September 19, 2023, the Movement Disorders Policy Coalition (MDPC) sent a letter to Chairwoman Friedman and Chairman Lawn of…
On September 11, 2023, Aimed Alliance sent a letter to Centers for Medicare and Medicaid Services (CMS) commenting on CMS’s…
On January 17, 2023, the Institute for Clinical and Economic Review (ICER) published its second annual “Barriers to Fair Access”…
On November 26, 2021, Aimed Alliance sent a letter to U.S. Senators Carper, Coons, Cortez, Masto, Menendez, Murray, Sinema, Schumer and Wyden…
On October 12, 2021, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) on its proposed rule…